January 21, 2022 Comments Off on New patent for Amgen Inc drug OTEZLA Posted in: Patent Added Annual Drug Patent Expirations for OTEZLA Otezla is a drug marketed by Amgen Inc and is included in one NDA. It is available from three suppliers. There are eleven patents…
The post New patent for Amgen Inc drug OTEZLA appeared first on DrugPatentWatch…
January 21, 2022 Comments Off on New patent for Bausch drug ZYCLARA Posted in: Patent Added Annual Drug Patent Expirations for ZYCLARA Zyclara is a drug marketed by Bausch and is included in one NDA. It is available from three suppliers. There are seven patents protecting…
The post New patent for Bausch drug ZYCLARA appeared first on DrugPate…